The Patent Finder
US

Console for Use in Power Assisted Lipoplasty

US D669,993 Term ended
OverviewAssignmentsSources & methods
Collateral for a security interest recorded Jun 13, 2025 (JPMorgan Chase Bank, N.A.).

Term ended Oct 30, 2026 · High confidence

Filed Sep 29, 2010 as application 29/375,932 · Granted Oct 30, 2012
Base term, 14 years from grant
Today
14 years from grant
Term ended Oct 30, 2026
2012 2026
Clock starts
Oct 30, 2012
Term ended
Oct 30, 2026
base term after the term ends Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US D669,992, to Oct 30, 2026. The term already ends on or before that date, so the cap shortened nothing.
14 years from grant
Base term
No maintenance fees are payable on this kind of patent.

This patent's term is its base term, 14 years from grant, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. No maintenance fees are payable on this kind of patent. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 14 years from grantGranted Oct 30, 2012Oct 30, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US D669,992)resolves to Oct 30, 2026, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Computed term endThe steps above, in orderOct 30, 2026High confidence

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 26, 2011
Reel 26183, frame 981
Merchant, Adnan I.; Siebrecht, Wayne A.; Mogill, David B.Sound Surgical Technologies LLCAssignment of Assignor's Interest
May 2, 2011
Reel 26210, frame 237
Sound Surgical Technologies LLCSilicon Valley BankSecurity Agreement
Nov 19, 2013
Reel 31674, frame 568
Sound Surgical Technologies, LLCCapital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P.Short-Form Patent Security Agreement
Nov 19, 2013
reel/frame not recorded
Sound Surgical Technologies, LLCCapital Royalty Partners II L.P.Short-Form Patent Security Agreement
Nov 19, 2013
reel/frame not recorded
Sound Surgical Technologies, LLCCapital Royalty Partners II - Parallel Fund "a" L.P.Short-Form Patent Security Agreement
Nov 19, 2013
reel/frame not recorded
Sound Surgical Technologies, LLCParallel Investment Opportunities Partners II L.P.Short-Form Patent Security Agreement
Jan 27, 2014
Reel 32127, frame 129
Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P.Sound Surgical Technologies LLCRelease of Security Interest in Patents
Jan 27, 2014
Reel 32127, frame 587
Silicon Valley BankSound Surgical Technologies LLCRelease of Security Interest in Patents
Mar 11, 2019
Reel 48556, frame 758
Bausch Health Americas, Inc.; Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Interest
May 12, 2021
Reel 56214, frame 690
Sound Surgical Technologies LLCSolta Medical, Inc.Merger
Jun 8, 2021
Reel 56811, frame 814
Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Interest
Feb 10, 2022
Reel 59121, frame 1
Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc.The Bank of New York MellonSecurity Agreement
Jun 13, 2022
Reel 60346, frame 705
Bausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland LimitedThe Bank of New York MellonSecurity Interest
Oct 4, 2022
Reel 61595, frame 66
Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Agreement (First Lien)
Oct 5, 2022
Reel 61606, frame 468
Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Agreement (Second Lien)
Jun 13, 2025
Reel 71564, frame 463
Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc.The Bank of New York MellonU.S. Patent Security Agreement
Jun 13, 2025
Reel 71566, frame 200
Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc.Jpmorgan Chase Bank, N.a.U.S. Patent Security Agreement
Nov 20, 2025
Reel 73654, frame 242
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
Reel 73654, frame 300
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb IncorporatedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health US, LLCRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSolta Medical, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentMedicis Pharmaceutical CorporationRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Ltd.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSantarus, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentOrapharma, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentPrecision Dermatology, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Companies Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health, Canada Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Ireland LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSolta Medical Ireland LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center

No maintenance fees are payable on this kind of patent, so the record carries no fee events.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited